| | Control () | ICH | -value | | Good outcome (mRS, 0–2), | Poor outcome (mRS, 3–6), |
| Age, yr | 63.2 (9) | 65.4 (8) | 67.4 (10) | NS | Sex (M/F, %) | 61.4/ | 59.8 | 65.3 | NS | Time from onset to admission, hr | | 6.5 (3.2–9.5) | 5.9 (2.6–8.7) | NS | History of vascular risk factors (%) | | | | | Hypertension | 42.1 | 75.5** | 72.6** | .0003 | Diabetes | 23.8 | 26.5 | 24.7 | NS | Smoking habit (current) | 16.5 | 11.7 | 15.3 | NS | Alcohol consumption | 18.7 | 21.6 | 26.8 | NS | Prior medication with | | | | | Lipid-lowering drugs | 26.6 | 18.9 | 28.5 | NS | Platelet inhibitors | 33.0 | 28.6 | 31.4 | NS | Vital signs | | | | | Systolic blood pressure, mmHg | | 178 (32) | 176 (28) | NS | Diastolic blood pressure, mmHg | | 101 (16) | 98 (22) | NS | Maximal SBP in 24 hr, mmHg | | 198 (26) | 192 (24) | NS | Maximal DBP in 24 hr, mmHg | | 110 (12) | 108 (9) | NS | Body temperature, () | | 36.5 (0.62) | 36.2 (0.81) | NS | Glasgow scale at baseline | | 15 (14-15) | 12 (10–14) | .001 | NIHSS at 10 days | | 9 (5–15) | 21 (16–24) | .001 | mRS at 3 month | | 1.8 (0–2) | 4 (3–6) | .001 | Neuroimaging findings | | | | | Topography, % lobar | | 45.2 | 42.8 | NS | ICH volume at baseline, mL | | 14.8 (6.8–22.0) | 34.2 (15.0–52.4) | .001 | Edema volume at baseline, mL | | 3.2 (1.2–9.0) | 12.0 (5.2–14.8) | .01 | ICH growth at 72 hours, ratio | | 0.08 (0.0–0.41) | 0.11 (0.02–0.46) | NS | ICH growth at 7 days, ratio | | 0.32 (0.55–0.02) | 0.01 (0.19–0.29) | .01 | Edema growth at 72 hours, ratio | | 0.65 (0.03–4.32) | 0.88 (0.46–3.34) | NS | Edema growth at 7 days, ratio | | 0.94 (0.00–3.10) | 1.21 (0.12–2.54) | NS | Intraventricular bleeding, % | | 11.5 | 53.4 | <.001 | Mass effect, % | | 21.0 | 68.5 | <.001 | Laboratory parameters | | | | | Serum glucose, mg/dL | | 125 (23) | 117 (36) | NS | Platelet count, 1000/mmc | | 226 (72) | 241 (69) | NS | Leukocyte count, 1000/mmc | | 7.8 (2.0) | 8.1 (1.8) | NS | Plasma fibrinogen, mg/dL | | 455 (120) | 447 (116) | NS | IL-6, pg/mL | | 102.6 (35.6) | 184.2 (38.4) | .01 |
| TNF-, pg/mL | | 54.3 (15.2) | 95.3 (18.5) | .05 |
|
|